Business Context and Reporting Period
This Form 8-K is filed by MEI Pharma, Inc. (not Lite Strategy, Inc.) on March 18, 2020. The report addresses a corporate governance amendment approved by the Board of Directors on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate bylaws and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the amendment of the Company's Second Amended and Restated Bylaws to the Third Amended and Restated Bylaws. This amendment permits the Company's annual meeting of stockholders to be conducted by means of remote communication, effective immediately.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly procedural regarding the bylaw amendment.
Investor Verification Checklist
- Verify the company name is MEI Pharma, Inc. (Ticker: MEIP), not Lite Strategy, Inc.
- Confirm the effective date of the remote meeting provision is March 18, 2020.
- Review the attached Exhibit 3.1 (Third Amended and Restated Bylaws) for full legal text.
- Note that no financial data is included in this specific filing.